Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matrices

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 12, 2002, Pages 3883-3891

  Yeaman, Michael R ^a,c,d   Gank, Kimberly D ^c   Bayer, Arnold S ^a,c,d   Brass, Eric P ^b,c,d  

^a Division of Infectious Diseases   (United States)

^b Center for Clinical Pharmacology   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; PROTEIN; PROTEIN RP 1; PROTEIN RP11; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; PEPTIDE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; COLONY FORMING UNIT; DRUG EFFICACY; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; DRUG EFFECT; SERUM BACTERICIDAL ACTIVITY;

ANTI-BACTERIAL AGENTS; BLOOD BACTERICIDAL ACTIVITY; ESCHERICHIA COLI; GENTAMICINS; PEPTIDES;

EID: 0036895275     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.12.3883-3891.2002     Document Type: Article

References (25)

1. Darveau, R. P., J. Blake, C. L. Seachord, W. L. Cosand, M. D. Cunningham, L. Cassiano-Clough, and G. Maloney. 1992. Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity. J. Clin. Investig. 90:447-455.
2. Fuursted, K. 1997. Postexposure factors influencing the duration of postantibiotic effect: Significance of temperature, pH, cations, and oxygen tension. Antimicrob. Agents Chemother. 41:1693-1696.
3. Hostacka, A. 1998. Serum sensitivity and cell surface hydrophobicity of Klebsiella pneumoniae treated with gentamicin, tobramycin, and amikacin. J. Basic Microbiol. 38:383-388.
4. Koo, S. P., M. R. Yeaman, and A. S. Bayer. 1996. Staphylocidal action of thrombin-induced platelet microbicidal protein is influenced by microenvironment and target cell growth phase. Infect. Immun 64:3758-3764.
5. Krijgsveld, J., S. A. Zaat, J. Meeldijk, P. A. van Veelen, G. Fang, B. Poolman, E. Brandt, J. E. Ehlert, A. J. Kuijpers, G. H. Engbers, J. Feijen, and J. Dankert. 2000. Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines. J. Biol. Chem. 275:20374-20381.
6. Lehrer, R. I., and T. Ganz. 2002. Defensins of vertebrate animals. Curr. Opin. Immunol. 14:96-102.
7. Lehrer, R. I., A. Barton, K. A. Daher, S. S. Harwig, T. Ganz, and M. E. Selsted. 1989. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J. Clin. Investig. 84:553-561.
8. Levy, O. 2000. Antimicrobial proteins and peptides of blood: Templates for novel antimicrobial agents. Blood 96:2664-2672.
9. Miglioli, P. A., U. Schoffel, and L. Gianfranceschi. 1996. The in vitro synergistic inhibitory effect of human amniotic fluid and gentamicin on growth of Escherichia coli. Chemotherapy 42:206-209.
10. Oh, J. E., S. Y. Hong, and K. H. Lee. 1999. Structure-activity relationship study: Short antimicrobial peptides. J. Pept. Res. 53:41-46.
11. Nanavaty, J., J. E. Mortensen, and T. R. Shryock. 1998. The effects of environmental conditions on the in vitro activity of selected antimicrobial agents against Escherichia coli. Curr. Microbiol. 36:212-215.
12. National Committee for Clinical Laboratory Standards. 2000. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 5th Ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
13. Peck-Miller, K. A., R. P. Darveau, and H. P. Fell. 1993. Identification of serum components that inhibit the tumoricidal activity of amphiphilic alpha helical peptides. Cancer Chemother. Pharmacol. 32:109-115.
14. Pruul, H., and P. J. McDonald. 1992. Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum. Antimicrob. Agents Chemother. 36:10-16.
15. Simmen, H. P., H. Battaglia, T. Kossmann, and J. Blaser. 1993. Effect of peritoneal fluid pH on outcome of aminoglycoside treatment of intraabdominal infections. World J. Surg. 17:393-397.
16. Vaara, M., P. Viljanen, T. Vaara, and P. H. Makela. 1984. A outer membrane-disorganizing peptide PMBN sensitizes Escherichia coli to serum bactericidal action. J. Immunol. 132:2582-2589.
17. Viljanen, P., H. Kayhty, M. Vaara, and T. Vaara. 1986. Susceptibility of gram-negative bacteria to the synergistic bactericidal action of serum and polymyxin B nonapeptide. Can. J. Microbiol. 32:66-69.
18. Wallis, R. S., M. Palaci, S. Vinhas, A. Hise, F. C. Ribeiro, K. Landen, S. H. Cheon, H. Y. Song, M. Phillips, R. Dieteze, and J. J. Ellner. 2001. A whole blood bactericidal assay for tuberculosis. J. Infect. Dis. 183:1300-1303.
19. Xiong, Y. Q., A. S. Bayer, and M. R. Yeaman. 2002. Inhibition of Staphylococcus aureus intracellular macromolecular synthesis by thrombin-induced platelet microbicidal proteins. J. Infect. Dis. 185:348-356.
20. Xiong, Y. Q., J. Caillon, H. Drugeon, G. Potel, and D. Baron. 1996. Influence of pH on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides and their postantibiotic effects. Antimicrob. Agents Chemother. 40:35-39.
21. Yan, H., and R. E. W. Hancock. 2001. Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob. Agents Chemother. 45:1558-1560.
22. Yeaman, M. R., Y. Q. Tang, A. J. Shen, A. S. Bayer, and M. E. Selsted. 1997. Purification and in vitro activities of rabbit platelet microbicidal proteins. Infect. Immun. 65:1023-1031.
23. Yeaman, M. R. 1997. The role of platelets in antimicrobial host defense. Clin. Infect. Dis. 25:951-970.
24. Yeaman, M. R., and A. S. Bayer. 1999. Antimicrobial peptides from platelets. Drug Resist. Updates 2:116-126.
25. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395.